South Korea selects five regions to host bio training campuses for foreign workers | Healthcare Asia Magazine
, South Korea
The Korean government and WHO in a MOU signing ceremony in May.

South Korea selects five regions to host bio training campuses for foreign workers

Foreign workers will be trained to produce biologicals like vaccines and therapeutics within the campuses.

Five regions in South Korea have been chosen to host the future global bio campuses dedicated to training biomanufacturing workers from developing countries, according to the Ministry of Health and Welfare.

The health agency said local training facilities will be built in Incheon Metropolitan City (Songdo), Gyeonggi-do (Siheung), Chungcheongbuk-do (Osong), Jeollanam-do (Hwasun), and Gyeongsangbuk-do (Andong) 

Around 2,000 people from low- and middle-income countries will be provided with training and education within these campuses each year to hone their skills in manufacturing biological products like vaccines and therapeutics, said Hwang Seunghyun, director-general of the global vaccine hub office at the health ministry.

The Global Bio Songdo Campus, a joint venture between Incheon City and Yonsei University, will serve as the main campus which will host the Workforce Training Hub Support Foundation.

Slated to open towards the end of 2024, the Songdo campus will be built with a gross floor area of 3,300 square metres equipped with lecture rooms, labs, and offices.

The newly launched project forms part of the country’s commitment with the World Health Organisation (WHO) to set up “Global Training Hub for Biomanufacturing” in 2022. 

The five locations were selected through a public contest aimed at selecting areas with training facilities, venue sites, and education capacity best suited to cater and integrate Korea’s bio-education capacity.

During the signing of a memorandum of understanding between the Korean government and WHO in May, WHO said establishing a global training centre will help boost local and regional production of biological products, such as insulin, monoclonal antibodies, and cancer medicines, among others.

Pemindaian AI terkini meningkatkan diagnosa di Shin Kong Wu Ho-Su Memorial Hospital

Rumah sakit di Taiwan ini menggunakan teknologi endoskop yang dibantu AI untuk mendeteksi polip dan kamera resolusi tinggi untuk telemedis.

KFSHRC Saudi bertumpu pada inovasi untuk mentransformasi layanan kesehatan

Rumah sakit ini mempercepat adopsi teknologi baru untuk memposisikan dirinya sebagai pemimpin global di bidang kedokteran.

Angkor Hospital merencanakan pusat trauma untuk anak-anak

Fasilitas ini akan memiliki ICU, ruang gawat darurat, ruang operasi, dan bangsal bedah.

Bali International Hospital dan HK Asia Medical mendirikan pusat jantung baru

Fasilitas ini akan menawarkan diagnostik, operasi invasif minimal, dan perawatan pasca operasi.

Pasar pencitraan medis Indonesia diproyeksikan tumbuh 6,12% CAGR hingga 2030

Salah satu pendorong utama adalah peningkatan inisiatif yang dipimpin pemerintah.

Rumah Sakit Pusat Kamboja beralih ke adopsi teknologi untuk meningkatkan layanan jantung

Salah satu teknologi kunci mereka adalah mesin ECMO untuk mendukung hidup yang berkepanjangan dalam kondisi kritis.

Ekspor farmasi Indonesia diperkirakan tumbuh 7,7% CAGR hingga 2028

Berkat upaya pemerintah dan aturan investasi baru untuk meningkatkan produksi domestik.

Jepang dan Indonesia tandatangani MoU untuk pelatihan perawat dan pekerja perawatan

Kemitraan ini bertujuan membimbing tenaga kesehatan Indonesia agar memenuhi standar tenaga kerja profesional Jepang.

Pusat gigi nasional Singapura berada di garda terdepan layanan gigi digital

Teknologi pemindaian intraoralnya menggantikan metode pencetakan gigi tradisional.

Inovasi medis global dan solusi berbasis AI menjadi sorotan

Medical Taiwan 2024 menghadirkan 280 peserta dari 10 negara dan mendorong integrasi teknologi dalam layanan kesehatan.